Transcriptional and post-transcriptional down-regulation of cyclin D1 contributes to C6 glioma cell differentiation induced by forskolin

Journal of Cellular Biochemistry

Volumn 112, Issue 9, 2011, Pages 2241-2249

  He, Songmin ^a,b   Zhu, Wenbo ^a   Zhou, Yuxi ^a   Huang, Yijun ^a   Ou, Yanqiu ^a   Li, Yan ^a   Yan, Guangmei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Cell cycle; Cyclin D1; Differentiation; Forskolin; Glioma; GSK 3B

Indexed keywords

CYCLIN D1; FORSKOLIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL PROLIFERATION; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLIOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; DOWN-REGULATION; ENZYME ACTIVATORS; FORSKOLIN; GENE EXPRESSION REGULATION; GLIOMA; GLYCOGEN SYNTHASE KINASE 3; PHOSPHORYLATION; PROTEOLYSIS; RATS; TRANSCRIPTION, GENETIC;

EID: 84860389987     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.23140     Document Type: Article

References (47)

1. Agami R, Bernards R,. 2000. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 102: 55-66.
2. Ammer H, Schulz R,. 1997. Regulation of stimulatory adenylyl cyclase signaling during forskolin-induced differentiation of mouse neuroblastoma× rat glioma (NG108-15) cells. Neurosci Lett 230: 143-146. (Pubitemid 27342186)
3. Brodsky A, Davio C, Shayo C, Lemos Legnazzi B, Barbosa M, Lardo M, Morelli A, Baldi A, Sanchez Avalos JC, Rivera E,. 1998. Forskolin induces U937 cell line differentiation as a result of a sustained cAMP elevation. Eur J Pharmacol 350: 121-127. (Pubitemid 28288317)
4. Cesi V, Tanno B, Vitali R, Mancini C, Giuffrida ML, Calabretta B, Raschella G,. 2002. Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation. Cell Death Differ 9: 1232-1239. (Pubitemid 35331770)
5. Chen B, Pan H, Zhu L, Deng Y, Pollard JW,. 2005. Progesterone inhibits the estrogen-induced phosphoinositide 3-kinase→AKT→GSK- 3beta→cyclin D1→pRB pathway to block uterine epithelial cell proliferation. Mol Endocrinol 19: 1978-1990. (Pubitemid 41124196)
6. Coghlan MP, Culbert AA, Cross DA, Corcoran SL, Yates JW, Pearce NJ, Rausch OL, Murphy GJ, Carter PS, Roxbee Cox L, Mills D, Brown MJ, Haigh D, Ward RW, Smith DG, Murray KJ, Reith AD, Holder JC,. 2000. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol 7: 793-803.
7. Cohen P, Frame S,. 2001. The renaissance of GSK3. Nat Rev Mol Cell Biol 2: 769-776. (Pubitemid 33679839)
8. Cuevas P, Diaz-Gonzalez D, Dujovny M,. 2004. Differentiation-inducing activity of neomycin in cultured rat glioma cells. Neurol Res 26: 401-403. (Pubitemid 38758462)
9. Dai C, Holland EC,. 2003. Astrocyte differentiation states and glioma formation. Cancer J 9: 72-81.
10. Dal Col J, Dolcetti R,. 2008. GSK-3beta inhibition: At the crossroad between Akt and mTOR constitutive activation to enhance cyclin D1 protein stability in mantle cell lymphoma. Cell Cycle 7: 2813-2816.
11. Diehl JA,. 2002. Cycling to cancer with cyclin D1. Cancer Biol Ther 1: 226-231.
12. Diehl JA, Cheng M, Roussel MF, Sherr CJ,. 1998. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12: 3499-3511. (Pubitemid 28553242)
13. Dufourny B, van Teeffelen HA, Hamelers IH, Sussenbach JS, Steenbergh PH,. 2000. Stabilization of cyclin D1 mRNA via the phosphatidylinositol 3-kinase pathway in MCF-7 human breast cancer cells. J Endocrinol 166: 329-338. (Pubitemid 30650570)
14. Georgopoulou N, Hurel C, Politis PK, Gaitanou M, Matsas R, Thomaidou D,. 2006. BM88 is a dual function molecule inducing cell cycle exit and neuronal differentiation of neuroblastoma cells via cyclin D1 down-regulation and retinoblastoma protein hypophosphorylation. J Biol Chem 281: 33606-33620. (Pubitemid 46036741)
15. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS, Jr. , 1999. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 19: 5785-5799. (Pubitemid 29339933)
16. Hershko A, Ciechanover A,. 1998. The ubiquitin system. Annu Rev Biochem 67: 425-479. (Pubitemid 28411135)
17. Holland EC,. 2000. Glioblastoma multiforme: The terminator. Proc Natl Acad Sci USA 97: 6242-6244. (Pubitemid 30412695)
18. Insel PA, Ostrom RS,. 2003. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol 23: 305-314. (Pubitemid 36676277)
19. Kawamata H, Tachibana M, Fujimori T, Imai Y,. 2006. Differentiation- inducing therapy for solid tumors. Curr Pharm Des 12: 379-385.
20. Kim BJ, Kim SS, Kim YI, Paek SH, Lee YD, Suh-Kim H,. 2004. Forskolin promotes astroglial differentiation of human central neurocytoma cells. Exp Mol Med 36: 52-56. (Pubitemid 38374724)
21. Klein PS, Melton DA,. 1996. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 93: 8455-8459. (Pubitemid 26269579)
22. Kroger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J, Hauser H,. 2007. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1. Cancer Res 67: 2972-2981. (Pubitemid 46724833)
23. Li Y, Yin W, Wang X, Zhu W, Huang Y, Yan G,. 2007. Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc Natl Acad Sci USA 104: 13438-13443. (Pubitemid 47293963)
24. Li Y, Lu H, Huang Y, Xiao R, Cai X, He S, Yan G,. 2010. Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells. Int J Cancer 127: 1271-1282.
25. Lin S, Wang W, Wilson GM, Yang X, Brewer G, Holbrook NJ, Gorospe M,. 2000. Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol Cell Biol 20: 7903-7913.
26. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
27. Ma J, Yu Z, Qu W, Tang Y, Zhan Y, Ding C, Wang W, Xie M,. 2010. Proliferation and differentiation of neural stem cells are selectively regulated by knockout of cyclin D1. J Mol Neurosci 42: 35-43.
28. Mayo C, Mayol X,. 2009. Cyclin D1 negatively regulates the expression of differentiation genes in HT-29 M6 mucus-secreting colon cancer cells. Cancer Lett 281: 183-187.
29. Nicholas MK,. 2007. Glioblastoma multiforme: Evidence-based approach to therapy. Expert Rev Anticancer Ther 7: S23-S27.
30. Nishi K, Inoue H, Schnier JB, Rice RH,. 2009. Cyclin D1 downregulation is important for permanent cell cycle exit and initiation of differentiation induced by anchorage-deprivation in human keratinocytes. J Cell Biochem 106: 63-72.
31. Ong CS, Zhou J, Ong CN, Shen HM,. Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3beta-Cyclin D1 pathway. Cancer Lett 298: 167-175.
32. Othumpangat S, Kashon M, Joseph P,. 2005. Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride. J Biol Chem 280: 25162-25169. (Pubitemid 40934608)
33. Pickart CM,. 2001. Mechanisms underlying ubiquitination. Annu Rev Biochem 70: 503-533. (Pubitemid 32663902)
34. Pines J,. 1999. Four-dimensional control of the cell cycle. Nat Cell Biol 1: E73-E79. (Pubitemid 129656015)
35. Prados MD, Levin V,. 2000. Biology and treatment of malignant glioma. Semin Oncol 27: 1-10. (Pubitemid 30390229)
36. Roz L, Gramegna M, Ishii H, Croce CM, Sozzi G,. 2002. Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc Natl Acad Sci USA 99: 3615-3620. (Pubitemid 34252155)
37. Spira AI, Carducci MA,. 2003. Differentiation therapy. Curr Opin Pharmacol 3: 338-343. (Pubitemid 36908936)
38. Strasberg Rieber M, Rieber M,. 1995. Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation. Biochem Biophys Res Commun 216: 422-427.
39. Takahashi-Yanaga F, Sasaguri T,. 2008. GSK-3beta regulates cyclin D1 expression: A new target for chemotherapy. Cell Signal 20: 581-589. (Pubitemid 351241128)
40. Takahashi-Yanaga F, Mori J, Matsuzaki E, Watanabe Y, Hirata M, Miwa Y, Morimoto S, Sasaguri T,. 2006. Involvement of GSK-3beta and DYRK1B in differentiation-inducing factor-3-induced phosphorylation of cyclin D1 in HeLa cells. J Biol Chem 281: 38489-38497. (Pubitemid 46041973)
41. Tashiro E, Tsuchiya A, Imoto M,. 2007. Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 98: 629-635. (Pubitemid 46563437)
42. Tasken K, Aandahl EM,. 2004. Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev 84: 137-167. (Pubitemid 38049878)
43. Wang C, Pattabiraman N, Zhou JN, Fu M, Sakamaki T, Albanese C, Li Z, Wu K, Hulit J, Neumeister P, Novikoff PM, Brownlee M, Scherer PE, Jones JG, Whitney KD, Donehower LA, Harris EL, Rohan T, Johns DC, Pestell RG,. 2003. Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation. Mol Cell Biol 23: 6159-6173. (Pubitemid 37013094)
44. Waxman S,. 2000. Differentiation therapy in acute myelogenous leukemia (non-APL). Leukemia 14: 491-496. (Pubitemid 30142878)
45. Wechsler-Reya R, Scott MP,. 2001. The developmental biology of brain tumors. Annu Rev Neurosci 24: 385-428. (Pubitemid 32695234)
46. Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z, Fang J,. 2008. Nestin and CD133: Valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27: 85.
47. Zhu B, Zhang LH, Zhao YM, Cui JR, Strada SJ,. 2006. 8-chloroadenosine induced HL-60 cell growth inhibition, differentiation, and G(0)/G(1) arrest involves attenuated cyclin D1 and telomerase and up-regulated p21(WAF1/CIP1). J Cell Biochem 97: 166-177. (Pubitemid 43050188)